Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Superior vena cava syndrome epidemiology and demographics
Introduction
Overview
Overview
Superior vena cava syndrome is a common oncologic emergency. The incidence rate in the United States is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; the median age of diagnosis is between 40-60 years. Males are more commonly affected with superior vena cava syndrome than females.
Epidemiology and Demographics
Epidemiology and Demographics
Prevalence
- The prevalence of superior vena cava syndrome remains unknown.[1]
Incidence
- In the United States, the incidence of superior vena cava syndrome is 15,000 individuals each year.[1]
Gender
- Males are more commonly affected with superior vena cava syndrome than females due to the higher incidence of lung cancer among males.[2]
Race
- The prevalence of SVCS does not vary by race. However, depending on the type of cancer a racial predilection may be possible.[1]
References
References
- ↑ 1.0 1.1 1.2 Higdon ML, Higdon JA (2006). “Treatment of oncologic emergencies”. Am Fam Physician. 74 (11): 1873–80. PMID 17168344.
- ↑ Carter BW, Erasmus JJ (2015). “Acute Thoracic Findings in Oncologic Patients”. J Thorac Imaging. 30 (4): 233–46. doi:10.1097/RTI.0000000000000148. PMID 25803363.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]